Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody

AIDS Research and Human Retroviruses

Volumn 20, Issue 7, 2004, Pages 755-762

  Kunert, Renate ^a   Wolbank, Susanne ^a   Stiegler, Gabriela ^a   Weik, Robert ^b   Katinger, Hermann ^a,b  

^a UNIVERSITY OF AGRICULTURAL SCIENCES   (Austria)

^b POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGEN BINDING; ANTIVIRAL ACTIVITY; ARTICLE; CHO CELL; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; HALF LIFE TIME; HUMAN IMMUNODEFICIENCY VIRUS 1; HYBRIDOMA; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SOMATIC MUTATION;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY COMPLEX; BASE SEQUENCE; CLONING, MOLECULAR; COMPLEMENTARITY DETERMINING REGIONS; GERM-LINE MUTATION; HIV-1; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN M; LYMPHOCYTES; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS;

EID: 3843139398     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/0889222041524571     Document Type: Article

References (35)

1. Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, and Shaw GM: Antibody neutralization and escape by HIV-1. Nature 2003;442(6929):307-312.
2. Kunert R, Steinfellner W, Purtscher M, Assadian A, and Katinger H: Stable recombinant expression of the anti HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO-cells. Biotechnol Bioeng 2000;67(1):97-103.
3. Stiegler G, Kunert R, Purtscher M, Wolbank S, Voglauer R, Steindl F, and Katinger H: A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 2001;17: 1757-1765.
4. Viveros M, Dickey C, Cotropia JP, Gevorkian G, Larralde C, Broliden K, Levi M, Burgess A, Cao C, Weiner DB, Agadjanyan MG, and Ugen KE: Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41. Virology 2000;270(1):135-145.
5. Zwick MB, Labrijn AF, Wang M, Spenlehauer C, Saphire EO, Binley JM, Moore JP, Stiegler G, Katinger H, Burton DR, and Parren PW: Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol 2001;75(22):10892- 10905.
6. Buchacher A, Predl R, Strutzenberger K, Steinfellner W, Trkola A. Purtscher M, Gruber G, Tauer C, Steindl F, and Jungbauer A: Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res Hum Retroviruses 1994;10(4):359-369.
7. Marks JD, Tristem M, Karpas A, and Winter G: Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes. Eur J Immunol 1991;21(4):985-991.
8. Sanger F, Nicklen S, and Coulson A: DNA sequencing with chain-terminating inhibitors. Biotechnol Bioeng 1992;24:104-108.
9. Horton RM, Cai ZL, Ho SN, and Pease LR: Gene splicing by overlap extension: Tailor-made genes using the polymerase chain reaction. Biotechniques 1990;8(5):528-535.
10. Max E and Korsmeyer S: Human J chain gene. Structure and expression in B lymphoid cells. J Exp Med 1985;161(4):832-849.
11. Purtscher M, Trkola A, Gruber G, Buchacher A, Predl R, Steindl F, Tauer C, Berger R, Barrett N, and Jungbauer A: A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1994;10(12):1651-1658.
12. Trkola A, Pomales AB, Yuan H, Korber B, Maddon PJ, Allaway GP, Katinger H, Barbas CF, Burton DR, and Ho DD: Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrametric CD4-IgG. J Virol 1995;69(11):6609-6617.
13. Reed L and Muench H: A simple method of estimating fifty percent endpoints. Am J Hyg 1938;27:493-497.
14. Matsuda F, Ishii K, Bourvagnet P, Kuma K, Hayashida H, Miyata T, and Honjo T: The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J Exp Med 1998;188(11):2151-2162.
15. Straubinger B, Huber E, Lorenz W, Osterholzer E, Pargent W, Pech M, Pohlenz HD, Zimmer FJ, and Zachau HG: The human VK locus. Characterization of a duplicated region encoding 28 different immunoglobulin genes. J Mol Biol 1988;199(1):23-34.
16. Kunert R, Rüker F, and Katinger H: Molecular characterization of five neutralizing anti-HIV type 1 antibodies: Identification of non-conventional D segments in the human monoclonal antibodies 2G12 and 2F5. AIDS Res Hum Retroviruses 1998;14(13): 1115-1128.
17. Jukes TH and King JL: Evolutionary nucleotide replacements in DNA. Nature 1979;281(5732):605-606.
18. Berdoz J, Blanc C, Reinhardt M, Kraehenbuhl J, and Corthesy B: In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells. Proc Natl Acad Sci USA 1999;96(6): 3029-3034.
19. Gorny MK, Xu JY, Karwowska S, Buchbinder A, and Zolla-Pazner S: Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120. J Immunol 1993;150(2): 635-643.
20. M Viau and Zouali M: Molecular determinants of the human antibody response to HIV-1: Implications for disease control. J Clin Immunol 2001;21(6):410-419.
21. Tomlinson IM, Walter G, Marks JD, Llewelyn MB, and Winter G: The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol 1992;227(3):776-798.
22. Bentley DL and Rabbits TH: Human immunoglobulin variable region genes - DNA sequences of two V kappa genes and a pseudogene. Nature 1980;288(5792):730- 733.
23. Schroeder HJ, Hillson J, and Perlmutter R: Structure and evolution of mammalian VH families. Int Immunol 1990;2(1):41-50.
24. Ueki Y, Goldfarb IS, Harindranath N, Gore M, Koprowski H, Notkins AL, and Casali P: Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus. J Exp Med 1990;171(1):19-34.
25. Kalinke U, Bucher EM, Ernst B, Oxenius A, Roost HP, Geley S, Kofler R, Zinkernagel RM, and Hengartner H: The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus. Immunity 1996;5(6):639-652.
26. Kalinke U, Oxenius A, Lopez-Macias C, Zinkernagel RM, and Hengartner H: Virus neutralization by germ-line vs. hypermutated antibodies. 2000;97(18):10126-10131.
27. Moore JP, Parren PW, and Burton DR: Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development. J Virol 2001;75(13):5721-5729.
28. Zwick MB, Parren PW, Saphire EO, Church S, Wang M, Scott JK, Dawson PE, Wilson IA, and Burton DR: Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120. J Virol 2003;77(10):5863-5876.
29. Cavacini L, Emes C, Power J, Desharnais F, Duval M, Montefiori D, and Posner M: Influence of heavy chain constant regions on antigen binding and HIV-1 neutralization by a human monoclonal antibody. J Immunol 1995;155(7):3638-3644.
30. Posner MR, Cavacini LA, Emes CL, Power J, and Byrn R: Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120. J Acquir Immune Defic Syndr 1993;6(1):7-14.
31. Dangl JL, Wensel TG, Morrison SL, Stryer L, Herzenberg LA, and Oi VT: Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J 1988;7(7):1989-1994.
32. Wolbank S, Kunert R, Stiegler G, and Katinger H: Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12. J Virol 2003;77(7):4095-4103.
33. Parren PW, Moore JP, Burton DR, and Sattentau QJ: The neutralizing antibody response to HIV-1: Viral evasion and escape from humoral immunity. AIDS 1999;13(Suppl. A):S137-162.
34. Ferko B, Katinger D, Grassauer A, Egorov A, Romanova J, Niebler B, Katinger H, and Muster T: Chimeric influenza virus replicating predominantly in the murine upper respiratory tract induces local immune responses against human immunodeficiency virus type 1 in the genital tract. J Infect Dis 1998;178(5):1359-1368.
35. Eckhart L, Raffelsberger W, Ferko B, Klima A, Purtscher M, Katinger H, and Ruker F: Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus. J Gen Virol 1996;77(Pt. 9):2001-2008.